The responsible representatives of the European Commission and the heads of the three EURLs have agreed upon a common position regarding the status of substances listed in Table 1 of CR (EU) No 37/2010 and the consequences for the validation of analytical methods in accordance with CIR 2021/808. The harmonised interpretation is provided on the Guidance Document Sub-page.